Global Biopharma Potency Assays Market Growth (Status and Outlook) 2025-2031

Report ID: 3037186 | Published Date: Jan 2026 | No. of Page: 115 | Base Year: 2025 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025

The global Biopharma Potency Assays market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics, the market is expected to be 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion US dollars in 2022.

Market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases contribute to growth. Additionally, funding from private and government organizations for development, and increased R&D activities for drugs are pivotal. However, there are challenges, including stringent regulations, high R&D costs, and patent expirations that companies must navigate to stay competitive.

The COVID-19 pandemic has further underscored the importance of vaccine development and supply chain management, emphasizing the necessity for agility and responsiveness among pharmaceutical companies.

Key Features

  • Detailed analysis of Biopharma Potency Assays sales by region and sector.
  • Insights into product segmentation, company formation, and market share.
  • Evaluation of leading global companies’ strategies, focusing on their Biopharma Potency Assays portfolios.

Segmentation by Type

  • Intracellular Potency Assay
  • Extracellular Potency Assay

Segmentation by Application

  • Pharmaceutical
  • Cytology
  • Other

Market by Region

  • Americas
  • APAC
  • Europe
  • Middle East & Africa

Company’s Coverage

  • ARL Bio Pharma
  • BioPharm International
  • Charles River Laboratories
  • DiscoverX
  • Eurofins Scientific
  • Intertek
  • Kymos
  • Pacific BioLabs
  • Pharmaron
  • Promega
  • Sartorius
  • SGS
  • ViruSure
  • Zelle Biotechnology

Key Questions Addressed in this Report

  • What are the emerging trends in the Biopharma Potency Assays market?
  • What strategies are leading companies using to enhance their market presence?
  • What challenges are expected to impact the market growth?
Frequently Asked Questions
Biopharma Potency Assays report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biopharma Potency Assays report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biopharma Potency Assays report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports